ACTRN12613000910707已完成不适用
Effect of Baclofen sustained release vs placebo on alleviation of reflux symptoms in patients with Gastroesophageal reflux disease
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 60 Years(—)
- 性别
- All
入选标准
- •patients with diagnosis of Gastroesophageal reflux disease on the basis of Rome 3 criteria
排除标准
- •1.history of Hypersensivity to baclofen
- •2.renal or hepatic failure
- •3.Neurological diseases
- •4.pregnant women
- •5.breastfeeding women
研究者
相似试验
招募中
2 期
The effect of baclofen on methamphetamine dependent subjects.Methamphetamine AddictionMental Health - AddictionNeurological - Other neurological disordersACTRN12616001614482inear Clinical Research Ltd18
尚未招募
3 期
A pilot investigation of the effects of Baclofen on a quantitative electroencephalographic predictor of relapse to alcohol dependence.Alcohol Use DisorderMental Health - Other mental health disordersACTRN12613000372785Royal Adelaide Hospital20
尚未招募
4 期
A study to compare whether oral baclofen or oral tizanidine is better in patients presenting with tightness of the upper limb after stroke.CTRI/2024/03/064651Jalpaiguri Government Medical College and Hospital
进行中(未招募)
不适用
A placebo controlled trial with Baclofen for the treatment of GERD patients with incomplete PPI responseGastroesophageal reflux diseaseEUCTR2009-017351-96-BEZleuven
进行中(未招募)
1 期
Study investigating the effect of baclofen in patients with postprandial regurgitation or belchingRumination syndrome and supragastric belchingMedDRA version: 14.0Level: LLTClassification code 10039292Term: Rumination disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.0Level: LLTClassification code 10004222Term: BelchingSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-002745-35-BEZLeuven20
